The parties arrive at a comprehensive non-cash settlement and agree to withdraw all respective claims against each other

NCLT to hear cases related to AMW Motors, Varia Engineering, McLeod Russel India, Jaypee Cement and Supreme Infrastructure

NCLT to hear cases related to Tulip Hotels, Colour Roof (India), Bhupesh Steel, Wind World (India), Manjeera Constructions

NCLT to hear cases related to Siti Networks, Sumeet Industries, Topworth Pipes, Athena Demwe Power, House of Kieraya and NCR Rail Infrastructure

The non-bank lender sets the rights issue price at 300 rupees per share

NCLT to hear cases related to Topworth Pipes & Tubes, Shree Ram Urban Infrastructure, Shivpriya Cables and Aban Offshore

NCLT to hear cases related to Eros International, RattanIndia Power, Reliance Capital, SpiceJet, Think & Learn and Shapoorji Pallonji & Co

NCLT to hear cases related to Jet Airways, Cox & Kings, Mumbai Metro One, Punj Lloyd and Jaypee Infratech

NCLT to hear cases related to Coastal Energy, Reliance Innoventures, Virgo Realtors and S Kumars Nationwide

NCLT to hear cases related to Mcleod Russel India, Punj Lloyd, Arisu Retail, Parsvnath Developers and Jet Airways

NCLT to hear cases related to Go Airlines, Siti Networks, Future Retail, Shapoorji Pallonji, Aban Offshore, Future Enterprises and Kitply Industries

NCLT to hear cases related to Future Lifestyle, Morarjee Textiles, Lok Housing & Construction and Supertech ORB Project

Fitch says weaker EBITDA and higher finance costs resulted in negative free cash flow and a surge in its parent UPL's leverage

NCLT to hear cases related to Steelco Gujarat, Bheema Cements, KSK Mahanadi Power, Mcleod Russel India and KS Oils

NCLT to hear cases related to Vadraj Cement, Punj Lloyd, Avantha Holdings, Shirpur Power and Satra Properties India

All the tribunal benches will resume normal functioning from Monday (4 November), except Guwahati and Mumbai

NCLT to hear cases related to Ezeego One Travels and Tours, Siti Networks, Avantha Holdings and GVK Gautami Power

Jefferies says Mankind Pharma has the potential to consistently outperform industry growth and improve margins consistently